Tefibazumab | Interleukin Related interleukin-related.com

Product Name :
Tefibazumab

Search keywords :
Tefibazumab

drugId :
null

Target Vo:
Epithelial cell adhesion molecule

Target Vo Short Name :
EpCAM

Moa_Name:
Epithelial cell adhesion molecule inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Bristol-Myers Squibb Company

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Bacteremia

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Racotumomab In Vitro
Bedinvetmab Neuronal Signaling
CXCL10/IP10 Antibody: CXCL10/IP10 Antibody is an unconjugated, approximately 10 kDa, rabbit-derived, anti-CXCL10/IP10 polyclonal antibody. CXCL10/IP10 Antibody can be used for: ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, background without labeling.

Author: Interleukin Related

Related Posts